Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03995355 · ClinicalTrials.gov registry record
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
A clinical trial, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- 161
- Enrollment target
NCT03995355 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 161 participants.
The verdict
NCT03995355 has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
This is a double-masked, randomized, bilateral, 2-Arm parallel group study. Subjects are scheduled for 3 study visits (screening/baseline, 7-Day and 30-Day follow-up visits) over a period of one month.
Interventions
- DEVICE 9618X investigational lipid eye drops
- DEVICE Blink® Tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2019-09-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03995355
The ClinicalTrials.gov registry entry for NCT03995355 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 9618X investigational lipid eye drops is the first listed.
NCT03995355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03995355 about?
NCT03995355 is a clinical study titled "Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients". This is a double-masked, randomized, bilateral, 2-Arm parallel group study. Subjects are scheduled for 3 study visits (screening/baseline, 7-Day and 30-Day follow-up visits) over a period of one month.
What is the current status of trial NCT03995355?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2019-06-26. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT03995355?
The interventions under investigation include: 9618X investigational lipid eye drops (DEVICE), Blink® Tears (DEVICE).
Who is sponsoring clinical trial NCT03995355?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.